29.60
Oscar Health Inc stock is traded at $29.60, with a volume of 4.61M.
It is up +2.53% in the last 24 hours and down -4.30% over the past month.
Oscar Health Inc is a healthcare technology company built around a full stack technology platform and a relentless focus on serving its members. It offers Individual & Family plans and health technology solutions that power the healthcare industry. Oscar operates as one segment to sell insurance to individuals, families and employees through the federal and state-run healthcare exchanges formed in conjunction with the Patient Protection and Affordable Care Act (ACA) and leverages its technology platform to provide services via its Oscar offering.
See More
Previous Close:
$28.87
Open:
$29.02
24h Volume:
4.61M
Relative Volume:
0.84
Market Cap:
$9.14B
Revenue:
$13.30B
Net Income/Loss:
$-39.39M
P/E Ratio:
-48.56
EPS:
-0.6096
Net Cash Flow:
$2.80B
1W Performance:
-7.87%
1M Performance:
-4.30%
6M Performance:
+142.42%
1Y Performance:
+63.63%
Oscar Health Inc Stock (OSCR) Company Profile
Name
Oscar Health Inc
Sector
Industry
Phone
(646) 403-3677
Address
75 VARICK STREET, NEW YORK
Compare OSCR vs UNH, CVS, ELV, CI, HUM
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
OSCR
Oscar Health Inc
|
29.60 | 9.14B | 13.30B | -39.39M | 2.80B | -0.6096 |
|
UNH
Unitedhealth Group Inc
|
376.59 | 338.03B | 450.13B | 14.91B | 23.62B | 15.55 |
|
CVS
Cvs Health Corp
|
89.13 | 113.99B | 407.94B | 2.90B | 7.39B | 2.2771 |
|
ELV
Elevance Health Inc
|
396.09 | 85.90B | 201.11B | 4.95B | 6.29B | 22.50 |
|
CI
Cigna Group
|
272.01 | 71.88B | 278.13B | 6.74B | 7.66B | 23.60 |
|
HUM
Humana Inc
|
397.93 | 47.78B | 137.20B | 1.15B | 1.27B | 9.3439 |
Oscar Health Inc Stock (OSCR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-10-26 | Upgrade | Barclays | Equal Weight → Overweight |
| Jun-04-26 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| May-06-26 | Initiated | Wolfe Research | Peer Perform |
| Apr-20-26 | Upgrade | Jefferies | Underperform → Hold |
| Feb-12-26 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jan-09-26 | Upgrade | UBS | Sell → Neutral |
| Jan-05-26 | Upgrade | Barclays | Underweight → Equal Weight |
| Dec-11-25 | Initiated | Stephens | Equal-Weight |
| Nov-26-25 | Upgrade | Piper Sandler | Neutral → Overweight |
| Oct-14-25 | Initiated | Goldman | Neutral |
| Jul-25-25 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Jul-15-25 | Downgrade | UBS | Neutral → Sell |
| Jul-14-25 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jul-11-25 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| Jul-02-25 | Initiated | Barclays | Underweight |
| Jun-24-25 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Mar-13-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Dec-10-24 | Initiated | Jefferies | Underperform |
| Nov-06-24 | Downgrade | BofA Securities | Neutral → Underperform |
| Oct-07-24 | Initiated | UBS | Neutral |
| Jun-26-24 | Initiated | Piper Sandler | Overweight |
| May-30-24 | Downgrade | BofA Securities | Buy → Neutral |
| May-30-24 | Initiated | Robert W. Baird | Outperform |
| Mar-22-24 | Initiated | Raymond James | Outperform |
| Nov-02-23 | Upgrade | BofA Securities | Neutral → Buy |
| Jun-06-23 | Upgrade | BofA Securities | Underperform → Neutral |
| Nov-16-22 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Nov-14-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jun-15-22 | Downgrade | BofA Securities | Neutral → Underperform |
| May-26-22 | Downgrade | BofA Securities | Buy → Neutral |
| Feb-14-22 | Downgrade | Goldman | Neutral → Sell |
| Jan-06-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Dec-14-21 | Initiated | Goldman | Sell |
| Sep-10-21 | Initiated | Cowen | Market Perform |
| Mar-30-21 | Initiated | Wells Fargo | Overweight |
| Mar-29-21 | Initiated | BofA Securities | Buy |
| Mar-29-21 | Initiated | Cowen | Market Perform |
| Mar-29-21 | Initiated | Credit Suisse | Outperform |
| Mar-29-21 | Initiated | Goldman | Buy |
| Mar-29-21 | Initiated | Morgan Stanley | Overweight |
View All
Oscar Health Inc Stock (OSCR) Latest News
Oscar Health (OSCR) Stock Looks Cheap Relative To Its Earnings Path - Yahoo Finance
Oscar Health director Vanessa Wittman sells $806,000 in stock - Investing.com
Form 4 Oscar Health Inc For: 27 September By Investing.com - Investing.com Nigeria
Oscar Health: Market Share Gains Are Only Part Of The Plan - Seeking Alpha
Prediction: These 4 Stocks Could Double From Here - The Motley Fool
A Look at Oscar Health Inc (OSCR) After 5.4% Decline -- GF Value $24.39 vs Price $28.87 - gurufocus.com
Oscar Health, Inc. (OSCR) Stock Price, News, Quote & History - ca.finance.yahoo.com
Oscar Health, Inc. (OSCR) latest stock news and headlines - Yahoo Finance Australia
Can Oscar Health Sustain Its Profit Rebound as Medical Costs Rise? - Zacks Investment Research
All You Need to Know About Oscar Health (OSCR) Rating Upgrade to Strong Buy - Yahoo Finance
Best Momentum Stocks to Buy for September 23rd - Yahoo Finance Australia
Oscar Health upgraded to Strong Buy with $45 ta... - Pluang
Oscar Health: Investor Day Offered New TAM Forecast Which Is Very Bullish, If Smoothly Executed - Seeking Alpha
OSCR Looks 26.3% Overvalued on GF Value™ as Market Reacts to ACA Enrollment Changes - GuruFocus
Understanding the Setup: (OSCR) and Scalable Risk - Stock Traders Daily
Insider Selling: Oscar Health (NYSE:OSCR) Director Sells $806,000.00 in Stock - MarketBeat
OSCR Looks 22.5% Overvalued on GF Value™ Amid ACA Subsidy Cuts - GuruFocus
Oscar Health (NYSE:OSCR) Stock Price Down 6.4%Here's What Happened - MarketBeat
Zacks Investment Ideas feature highlights: Assurant, Hippo, Horace Mann Educators, MGIC Investment, Slide Insurance and Oscar Health - Yahoo Finance
Oscar Health, Inc. (OSCR) Stock Drops Despite Market Gains: Important Facts to Note - Yahoo Finance
Why Oscar Health (OSCR) Stock Is Down Today - Quiver Quantitative
Oscar Health (NYSE:OSCR) Shares Gap DownWhat's Next? - MarketBeat
Oscar Health, Inc. (OSCR) Stock Analysis: Revenue Growth and Strategic Positioning Drive Investor Interest - DirectorsTalk Interviews
Oscar Health, Inc. (OSCR) stock price, news, quote and history - Yahoo Finance UK
Oscar Health, Inc. (OSCR) Analyst/Investor DaySlideshow (NYSE:OSCR) 2026-09-19 - Seeking Alpha
Oscar Health (OSCR) Bets On Lucy As CEO Calls Time On Employer Coverage - simplywall.st
OSCR Stock Hits 5-Year High: Oscar Sees 'Healthy Tailwinds' In 2026 On Potential Upside To Guidance - Stocktwits
Oscar Health (OSCR) Targets Doubling EPS By 2027 - Yahoo Finance
Joshua Kushner's 12.1% Oscar Health (NYSE: OSCR) stake sits atop a dual-class voting setup - Stock Titan
Oscar Health Announces Thrive Capital’s Completion of Oscar Health Common Stock Distribution to its Limited Partners - Business Wire
Oscar Health CFO delivers takeaways from company’s Investor Day event - qz.com
Officer plans $806K Oscar Health (OSCR) stock sale - Stock Titan
OSCR Maintained by Raymond James -- Price Target Raised to $42 - GuruFocus
Despite Fast-paced Momentum, Oscar Health (OSCR) Is Still a Bargain Stock - Yahoo Finance
Oscar Health CFO Scott Blackley Shares Key Takeaways from its Investor Day - Yahoo Finance
Piper Sandler raises Oscar Health stock price target on ACA growth - Investing.com Nigeria
Oscar Health Is Rebranding to Make Healthcare Feel Human - Yahoo Finance
Oscar Health Stock Rises Following Raised 2026 Guidance and Wall Street Price Target Hikes - Benzinga
Oscar Health's 2029 Target Predicated on Solid Revenue Growth, UBS Says - marketscreener.com
Oscar Health CFO Delivers Takeaways from Company’s Investor Day Event - Yahoo Finance
Oscar Health (NYSE:OSCR): What’s Driving the Healthcare Shift? - Kalkine Media
'The era of employer health insurance is ending': Oscar Health CEO explains - Yahoo Finance
Oscar Health (NYSE:OSCR) Receives "Equal Weight" Rating from Stephens - MarketBeat
BofA raises Oscar Health stock price target on margin outlook - Investing.com
Tidal Investments LLC Makes New Investment in Oscar Health, Inc. $OSCR - MarketBeat
Oscar Health vs. Centene: Which ACA Insurer Is the Better Buy? - Yahoo Finance
OSCR Looks 33.9% Overvalued on GF Value™ as Oscar Health Revises 2026 Outlook - GuruFocus
Oscar Health Plans Major Obamacare Expansion Over Next Three Years - Yahoo! Finance Canada
Oscar Health improves full-year medical loss ratio, earnings outlook (OSCR:NYSE) - Seeking Alpha
Oscar Health raises 2026 operating earnings target to $600–$800M, tightens MLR guidance - tradingview.com
Here's Why Oscar Health, Inc. (OSCR) Fell More Than Broader Market - finance.yahoo.com
Oscar Health Inc Stock (OSCR) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):